Navigation Links
Solidica Awarded 2008 Best of Sensors Expo Honor for Breakthrough Battery Health Monitor
Date:6/23/2008

Battery-agnostic smart module combines integrated monitoring, prognostics &

wireless communication flexibility

ANN ARBOR, Mich., June 23 /PRNewswire/ -- For the third consecutive year, Solidica, Inc. is awarded Sensors Magazine's prestigious "Best of Sensors Expo Award" for product innovation and leadership. This year's Silver honor recognized Solidica's flagship battery health monitor: the Solo Volt(TM) Battery Health & Prognostics Module. The Magazine's editors select the Award recipients based on their uniqueness, utility, and potential to impact change in the marketplace.

Ideal for battery-reliant applications in harsh environments, the Solo Volt(TM) Battery Health Monitor measures voltage, current, temperature, State of Charge, and life remaining on individual batteries -- or sets of batteries -- ranging from 3V to 40V each. With a powerful battery monitoring and prognostics algorithm, each module is uniquely capable of monitoring multiple batteries simultaneously, while operating in ultra-low power consumption mode. Additionally, the battery-agnostic design makes the Solo Volt(TM) compatible with multiple battery types (lead-acid, NiMH, etc.) -- disposable and/or rechargeable, single or multiple cells -- from nearly any manufacturer, and for use in mobile and stationary applications alike.

Aside from the compatibility with an ample range of battery voltages, types and manufacturers, the versatile design includes direct communication and data integration with vehicle networks through multiple standard protocols, including J1939 CAN and J1708/1587. Resettable fuses, built-in power supply, and optional functions and wireless communication capabilities round off the award-winning product.

"We have engineered a new level of system compatibility and feature set to meet the demands of a variety of customers with converging requirements, many of whom have interdependent battery-powered systems and data management n
'/>"/>

SOURCE Solidica, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. UVa researcher awarded $3.6 million grant to fight drug-resistant bacteria
2. Southwest Ambulance Awarded Exclusive, 3-Year Contract Extension in Peoria, Arizona
3. CAS Medical Systems, Inc. Awarded $2.8 Million Grant by National Institutes of Health
4. PartsSource Awarded US Patent for PartsFinder(TM) Application
5. Wrigleys Orbit(R), Extra(R) and Eclipse(R) Sugar-Free Chewing Gums Awarded American Dental Associations Seal of Acceptance
6. Insulet Awarded National Accreditation for Excellence by Community Health Accreditation Program
7. Paragon Technologies SI Systems Brand Awarded A $1.0 Million System Expansion Contract for an Automated Light-Picking System
8. UMASS Medical School awarded National Childrens Study contract
9. beBetter Awarded WV Quitline Contract
10. Henricksen Awarded 2007 Distinguished Veterinary Staff Award
11. Lacey Veterinarian Awarded 2007 WSVMA Recent Graduate Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)...rasylol have a higher death risk, data review find...-- A new study casts more doubt on the safety of t...ng in patients undergoing surgery. , Trasylol i... States, where it was removed from the market in 2...n researchers reviewed findings from 49 randomized...
(Date:12/2/2008)...Dec. 2 Seniors, disable...ompanies gathered today to,oppose efforts by Blue...tion,through the lame duck session of the Legisla...death for many of us in Michigan," said,RoAnne Ch...ility Rights,Coalition. "A vote for this bill is ...
(Date:12/2/2008)...o)Rare injuries accounted for 3.5 percent of high ...ding to the first study to examine rare injuries a...njuries include eye injuries, dental injuries, nec...llness, which may result in high morbidity, costly...ences. , Football was associated with the highes...
(Date:12/2/2008)... Today, advocates for t...ntry are coming together at Liz,Claiborne Inc. to...top Teen,Dating Abuse. Ann and Chris Burke, educa...dered by her abusive ex-boyfriend, are joining eff... on this national coalition that will,consist of ...
Breaking Medicine News(10 mins):Health News:Another Study Warns of Risk From Cardiac Surgery Drug 2Health News:Opposition Continues to Grow to Blues' Legislation 2Health News:Opposition Continues to Grow to Blues' Legislation 3Health News:Parents of Murdered Dating Violence Victim, Legislators, and Teachers Unite to Launch 'MADE' - Moms and Dads for Education to Stop Teen Dating Abuse 2Health News:Parents of Murdered Dating Violence Victim, Legislators, and Teachers Unite to Launch 'MADE' - Moms and Dads for Education to Stop Teen Dating Abuse 3
...the National Institutes of Health, United States, ...t -of –interests. This involves going against the ...l advice and help to a private company. Sutherland...s accused of proving the giant drug company, Pfize...
...ugs and radiation. But recent studies reveal that ...e mortality of cancer victims by 50 to 60 percent....e benefits of exercise in the prevention of hear...ittle is known about the effects of exercise on ca...
...olesterol, blood pressure and cardio-vascular prob...-based laboratory//. Pharmacists at Dr Reddy’s ha...olesterol-lowering statin, two blood-pressure medi...e world’s first ‘polypill’ is expected to control ...
... in Mars as believed earlier but ‘very liquid, ver...cient water on Mars," said Ken Edgett, a scientist...conference. "Today, we are talking about liquid wa...s right now.” The pictures taken by NASA's Mars G...
Other Medicine News:Health News:Poly-pill – A Single Drug For Multiple Complaint 2
(Date:12/1/2008)...e-USNewswire/ -- New research has found that the a...ography (CT) scanner in an emergency room can sign...o receive a potentially life-saving treatment. Res...l Center (NSMC)-Salem Hospital in Salem, Mass., wi... Radiological Society of North America (RSNA). , ...
(Date:12/1/2008)...ire/ -- TargeGen has announced that an oral,prese...r, US-based clinical,trial of TG101348 in myelopr...,the 2008 American Society of Hematology (ASH) Me...as follows:, Title: A Phase I S... JAK2-Selective Inhibitor, in Patie...
(Date:12/1/2008)...tasia Treated With ENB-0040 at Children,s Hospital...NTREAL, Dec. 1 Enobia Pharma, an e...ping novel therapeutics for serious bone disorders... its clinical program for hypophosphatasia was dos...rapy (ERT) with ENB-0040 for the treatment of this...
(Date:12/1/2008).... 1 Genaera Corporation...subjects has begun in study MSI-1436C-102 (Study 1... trodusquemine (MSI-1436) in overweight and obese ...for the treatment of type 2 diabetes and obesity w...insulin and leptin pathways through the highly sel...
Breaking Medicine Technology:Portable CT Increases Chance of Stroke Survival and Recovery 2Portable CT Increases Chance of Stroke Survival and Recovery 3Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 2Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 3Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 4Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 5Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics 2Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics 3Alpharma Announces Positive Results From Pivotal Phase III Efficacy Trial on ALO 01 28EMBEDA 28TM 29 29 28morphine sulfate extended release with seq 2998 1Alpharma Announces Positive Results From Pivotal Phase III Efficacy Trial on ALO 01 28EMBEDA 28TM 29 29 28morphine sulfate extended release with seq 2998 2Alpharma Announces Positive Results From Pivotal Phase III Efficacy Trial on ALO 01 28EMBEDA 28TM 29 29 28morphine sulfate extended release with seq 2998 3Alpharma Announces Positive Results From Pivotal Phase III Efficacy Trial on ALO 01 28EMBEDA 28TM 29 29 28morphine sulfate extended release with seq 2998 4Alpharma Announces Positive Results From Pivotal Phase III Efficacy Trial on ALO 01 28EMBEDA 28TM 29 29 28morphine sulfate extended release with seq 2998 5A reputation for innovation 4796 1A reputation for innovation 4796 2Governor Rendell Announces Resignation of Health Secretary Dr Calvin Johnson 26201 1Governor Rendell Announces Resignation of Health Secretary Dr Calvin Johnson 26201 2Online Health Information Category Grows at Rate Four Times Faster Than Total Internet 26196 1Online Health Information Category Grows at Rate Four Times Faster Than Total Internet 26196 2Online Health Information Category Grows at Rate Four Times Faster Than Total Internet 26196 3Online Health Information Category Grows at Rate Four Times Faster Than Total Internet 26196 4
...22, 2007 /PRNewswire/ -- Principal,investigators f...roliferative for Restenosis) trial, the pivotal st...luting coronary stent,presented today the clinica...investigators confirmed that the study failed to m...ed this conclusion in a,press release on Monday, M...
... FDA Approval of SEROQUEL XR--, WILMINGTON, Del., ... today announced that two analyses from a large-sc...EL XR(TM) (quetiapine,fumarate) Extended-Release T... schizophrenia in adult patients, were presented t...tric Association,(APA). These analyses from the cl...
Other Medicine Technology:Investigators Report COSTAR II Pivotal Drug-Eluting Stent Trial,Results at EuroPCR 2007 2Investigators Report COSTAR II Pivotal Drug-Eluting Stent Trial,Results at EuroPCR 2007 3New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release,Tablets as Effective Treatment for Schizophrenia 2New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release,Tablets as Effective Treatment for Schizophrenia 3New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release,Tablets as Effective Treatment for Schizophrenia 4New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release,Tablets as Effective Treatment for Schizophrenia 5New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release,Tablets as Effective Treatment for Schizophrenia 6New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release,Tablets as Effective Treatment for Schizophrenia 7New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release,Tablets as Effective Treatment for Schizophrenia 8New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release,Tablets as Effective Treatment for Schizophrenia 9
Wipe + Wick
Ophthalmic Ring
Lacrimal Cannula, Straight, Stepped DownSize: 19g x 1-1/2".
PremierEdge™ Slit Knives.
Medicine Products: